Sign in

CIK 0001649904 · Large accelerated filer

RHYTHM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RYTM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
462159271
Phone
857-264-4280
Business address
222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
Former names
RHYTHM METABOLIC, INC.
  1. 4 Planned sale President and CEO sold 50,000 shares at an average $102.67 ($5,133,442)
  2. 4 Planned sale Chief Financial Officer sold 62,774 shares at an average $105.46 ($6,619,913)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Planned sale Chief Technical Officer sold 5,079 shares at $119.75 ($608,210)
  6. 4 Planned sale Chief Scientific Officer sold 7,763 shares at an average $117.57 ($912,703)
  7. 4 Planned sale EVP, Head of North America sold 75,834 shares at $117.38 ($8,901,531)
  8. 4 Planned sale EVP, Head of International sold 57,000 shares at an average $116.15 ($6,620,575)
  9. 4 Shares withheld for taxes Chief Scientific Officer gave up 2,150 shares (to pay taxes)
  10. 4 Option exercise Director acquired 4,712 shares (option exercise)
  11. 4 Option exercise Director acquired 4,712 shares (option exercise)
  12. 4 Option exercise Director acquired 4,712 shares (option exercise)
  13. 4 Option exercise Director acquired 4,712 shares (option exercise)
  14. 4 Option exercise Director acquired 4,712 shares (option exercise)
  15. 4 Planned sale Director sold 37,000 shares at $100.32 ($3,711,896)
  16. 4 Option exercise Chief Financial Officer acquired 3,000 shares (option exercise)
  17. 4 Open-market sale Corporate Controller & CAO sold 4,643 shares at $92.21 ($428,131)
  18. 4 Option exercise EVP, Head of International acquired 12,875 shares (option exercise)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 1 of 22 · 430 filings